Breast cancer patients who have been in remission for years or even decades may still need to be cautious about respiratory infections. Some common viruses may re-awaken a very small number of dormant breast cancer cells within our lungs, according to emerging research. “Dormant cancer cells are like the embers left in an abandoned campfire, and respiratory viruses are like …
Read More »
Visit the News Hub Software developed at WashU Medicine on accelerated path to approval Getty Images A new AI-based technology developed at WashU Medicine analyzes mammograms to provide a more accurate prediction of an individual’s risk of developing breast cancer over the next five years. The software has now received the FDA’s Breakthrough Device designation. A new technology that harnesses …
Read More »
‘RHOD’ Star D’Andra Simmons I Have Breast Cancer Published July 29, 2025 4:35 PM PDT D’Andra Simmons has revealed she’s been diagnosed with breast cancer. The 56-year-old reality star opened up about her diagnosis for the first time on Instagram Monday sharing she’s receiving care at the UTSW Simmons Cancer Center, which her uncle and his foundation established almost 30 …
Read More »Celcuity’s breast cancer combo hits goals, teeing up FDA filing Fierce Biotech Celcuity Stock Triples on Positive Breast Cancer Treatment Study Yahoo Finance Celcuity’s triple cancer drug combo beats AstraZeneca in halting cancer progression, shows study Mint Celcuity posts Phase 3 win in breast cancer, setting up challenge to Novartis and Roche Endpoints News Gedatolisib Triplet Boosts Progression-Free Survival in Breast Cancer Curetoday Source link
Read More »
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study presented at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, California. “Obesity is a significant risk factor for breast cancer, and while it is very preliminary data, our studies in mice suggest …
Read More »
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “Obesity is a significant risk factor for breast cancer, and while it is very preliminary data, our studies in …
Read More »
Despite concerns about cognitive decline after cancer treatment, most breast cancer survivors show no increased risk of developing Alzheimer’s disease, and some may have a slightly lower risk than their cancer-free peers, according to a large retrospective study from Korea. However, any apparent protective effect faded with time, the investigators reported online in JAMA Network Open. Overall, this is “reassuring …
Read More »